Session Information
2007 Midyear Clinical Meeting
Considerations and Opportunities for Your Investigational Drug Service
Track: Educational Session
Program Code: 257-L04
Date: Tuesday, December 4, 2007
Time: 2:00 p.m. - 5:00 p.m.
Location:
Bellini 2005/2006/2105/2106MEETING PLANNING ASSOCIATE:
Dr. Joanna Louie, PharmD, CCRC, Corporate Manager, Clinical Research/IDS, Grants & Research Administration, Atlantic Health
MODERATOR:
Dr. Joanna Louie, PharmD, CCRC, Corporate Manager, Clinical Research/IDS, Grants & Research Administration, Atlantic Health
PRESENTERS:
Dr. Joanna Louie, PharmD, CCRC, Corporate Manager, Clinical Research/IDS, Grants & Research Administration, Atlantic Health
John Petrich, RPh, MS, Investigational Drug Service Coordinator, Cleveland Clinic
Ms. Janet Mighty, RPh, MBA, Assistant Director, Investigational Drug Service, Johns Hopkins Hospital
Dr. Robert Granko, PharmD, MBA, Assistant Director, University of North Carolina Hospitals
Dr. Jennifer Christensen, PharmD, Clinical Pharmacist II, Investigational Drug Services, Ben Taub General Hospital
Dr. Joanne Whitney, PharmD, PhD, Director, Drug Product Services Laboratory and Associate Professor, Department of Clinical Pharmacy, University of California San Francisco
LEARNING OBJECTIVES
- Describe methods to optimize operational and financial results.
- Identify advantages and disadvantages of different extemporaneous compounding services to meet the needs of the investigators.
- Discuss future directions and opportunities in clinical research.
Audio Synchronized to PowerPoint
Handout Online